Tumor evolution selectively inactivates the core microRNA machinery for immune evasion
Nat Communications_2021
Resource Topics
- Biophysic
- Cancer Research
- Discovery Chemistry
- Drug Discovery
- Hit Finding and Screening Services
- in vitro biology
- in vivo Pharmacology
- Infectious Diseases
- Liver Diseases
- Oncology & Immuno-oncology
- Pain
- Protein Services
- Structural Biology
- Target Validation
- Technologies
- Therapeutic Modalities